These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6083763)

  • 1. Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
    Bonadonna G; Santoro A; Viviani S; Lombardi C; Ragni G
    Arch Toxicol Suppl; 1984; 7():140-5. PubMed ID: 6083763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of chemotherapy in the management of early stage Hodgkin's disease.
    Rosenberg SA
    Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
    [No Abstract]   [Full Text] [Related]  

  • 5. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    Viviani S; Santoro A; Ragni G; Bonfante V; Bestetti O; Bonadonna G
    Eur J Cancer Clin Oncol; 1985 May; 21(5):601-5. PubMed ID: 2408897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 8. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Tombolini V; Capua A; Pompili E
    Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H
    Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
    [No Abstract]   [Full Text] [Related]  

  • 10. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
    Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
    Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
    [No Abstract]   [Full Text] [Related]  

  • 11. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Busia A; Laffranchi A; Viviani S; Bonfante V; Villani F
    Anticancer Res; 2010 Oct; 30(10):4381-7. PubMed ID: 21036768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
    Glick JH; Young ML; Harrington D; Schilsky RL; Beck T; Neiman R; Fisher RI; Peterson BA; Oken MM
    J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP.
    Anselmo AP; Cartoni C; Bellantuono P; Maurizi-Enrici R; Aboulkair N; Ermini M
    Haematologica; 1990; 75(2):155-8. PubMed ID: 1694156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
    Kornblith AB; Anderson J; Cella DF; Tross S; Zuckerman E; Cherin E; Henderson ES; Canellos GP; Kosty MP; Cooper MR
    Cancer; 1992 Nov; 70(10):2508-16. PubMed ID: 1384949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
    Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V; Jais JP; Colonna P; Andrieu JM
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.